Literature DB >> 26593455

Comparing perioperative processes of care in high and low mortality centers performing pancreatic surgery.

Christopher P Scally1, Huiying Yin1, John D Birkmeyer1, Sandra L Wong1.   

Abstract

BACKGROUND: Pancreatic surgery outcomes vary widely. We hypothesize that by comparing high and low mortality hospitals, we may identify differences in patient care impacting safety.
METHODS: We sampled hospitals with very-low and very-high mortality (LMH; HMH) and conducted on-site chart reviews evaluating perioperative care practices for pancreatic operations.
RESULTS: HMHs had an 11.6% mortality rate; LMHs 1.5%. Patients in HMHs had worse ASA classification (20.9% ASA Class 4/5 vs. 2.0%, P < 0.001) and comorbidity burden (55.3% with ≥ 1 comorbidity vs. 39.6%, P = 0.037). At HMHs, operations took longer (353.9 min vs. 313.7 min, P = 0.05), had higher blood loss (1,203.7 ml vs. 881.6 ml, P = 0.04), and patients underwent more transfusions (70.2% vs. 41.1%, P < 0.001). There were differences in anesthetic care: less invasive monitoring (76.1% vs. 93.1%, P < 0.001) and epidural pain management (22.5% vs. 62.9%, P < 0.001). Both cohorts had similar rates of VTE prophylaxis and SSI prevention compliance.
CONCLUSION: High and low mortality hospitals both have high compliance with common quality measures; however, HMHs performed worse in other areas of perioperative care, indicating possible targets for quality improvement efforts.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  inpatients/statistics and numerical data; neoplasms/surgery; outcome and process assessment; perioperative care; quality improvement/trends; quality of healthcare

Mesh:

Year:  2015        PMID: 26593455     DOI: 10.1002/jso.24085

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Potential impact of a volume pledge on spatial access: A population-level analysis of patients undergoing pancreatectomy.

Authors:  Zhi Ven Fong; Andrew P Loehrer; Carlos Fernández-Del Castillo; Yanik J Bababekov; Ginger Jin; Cristina R Ferrone; Andrew L Warshaw; Lara N Traeger; Matthew M Hutter; Keith D Lillemoe; David C Chang
Journal:  Surgery       Date:  2017-05-11       Impact factor: 3.982

2.  Do Patients Diagnosed with Metastatic Pancreatic Cancer Benefit from Primary Tumor Surgery? A Propensity-Adjusted, Population-Based Surveillance, Epidemiology and End Results (SEER) Analysis.

Authors:  Lai Wang; Lina Yang; Lianyu Chen; Zhen Chen
Journal:  Med Sci Monit       Date:  2019-11-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.